Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04377555 |
|---|---|
| Brief Title: | Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab. |
| First Submitted : | May 1, 2020 |
| First Submitted that Met QC Criteria : | May 5, 2020 |
| First Posted : | May 6, 2020 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 9, 2024 |